NuVasive (NUVA) Tops Q1 EPS by 9c

NuVasive (NASDAQ: NUVA) reported Q1 EPS of $0.30, $0.09 better than the analyst estimate of $0.21. Revenue for the quarter came in at $192.4 million versus the consensus estimate of $189.3 million.

NuVasive sees FY2015 EPS of $1.10, versus the consensus of $1.11. NuVasive sees FY2015 revenue of $810.0 million, versus the consensus of $811.1 million.

For earnings history and earnings-related data on NuVasive (NUVA) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)